Pharmaceutics

Cycloastragenol Provides Pharmacokinetic Advantages over Astragaloside IV with Enhanced Cochlear Exposure and Protection Against Age-Associated Hearing Dysfunction

By Yaqian Gao, Yiheng Liang, Haiyan Chen, Zhiyun Du

Experiments in animalsInterventions

The paper

Yaqian Gao, Yiheng Liang, Haiyan Chen, Zhiyun Du

Guangdong University of Technology

Pharmaceutics, 20 Aug 2026

doi.org/10.3390/pharmaceutics18081037 PubMed 42654154

Research Square2 Oct 2026
Gut microbes from hearing loss patients trigger inner ear damage in young mice
Aging Cell2 Oct 2026
IGF-1 and SLC25A33 preserve cochlear blood barrier integrity in aged mice
FASEB Journal2 Oct 2026
Astragaloside IV reduces cardiac aging in mice by restoring mitochondrial balance
Frontiers in Immunology4 Oct 2026
Fungus drives spleen aging in mice, eased by astragaloside IV